| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI
Department of Biochemistry and Molecular Genetics, University of Texas-Southwestern, Dallas, TX
The Skaggs Institute for Chemical Biology and Departments of Cell Biology and Chemistry, The Scripps Research Institute, La Jolla, CA
1 To whom correspondence should be addressed. e-mail: chillard{at}mcw.edu
N-Arachidonylethanolamine (AEA) accumulates during brain injury and postmortem. Because fatty acid amide hydrolase (FAAH) regulates brain AEA content, the purpose of this study was to determine its role in the postmortal accumulation of AEA using FAAH null mice. As expected, AEA content in immediately frozen brain tissue was significantly greater in FAAH-deficient (FAAH–/–) than in wild-type mice. However, AEA content was significantly lower in brains from FAAH–/– mice at 5 and 24 h postmortem. Similarly, wild-type mice treated in vivo with a FAAH inhibitor (URB532) had significantly lower brain AEA content 24 h postmortem compared with controls. These data indicate that FAAH contributes significantly to the postmortal accumulation of AEA. In contrast, the accumulations of two other N-acylethanolamines, N-oleoylethanolamine (OEA) and N-palmitoylethanolamine (PEA), were not reduced at 24 h postmortem in either the FAAH–/– mice or mice treated with URB532. FAAH–/– mice accumulated significantly less ethanolamine at 24 h postmortem compared with wild-type mice, suggesting that FAAH activity plays a role in the accumulation of ethanolamine postmortem.
These data demonstrate that FAAH activity differentially affects AEA and OEA/PEA contents postmortem and suggest that AEA formation specifically occurs via an ethanolamine-dependent route postmortem.
Abbreviations: AEA, N-arachidonylethanolamine; 2-AG, 2-arachidonylglycerol; FAAH, fatty acid amide hydrolase; LC-APCI-MS, atmospheric pressure, chemical ionization liquid chromatography/mass spectrometry; LC-ES-MS, liquid chromatography-electrospray ionization-mass spectrometry; NAE, N-acylethanolamine; NAPE, N-acylphosphatidylethanolamine; NAT, N-acyltransferase; OEA, N-oleoylethanolamine; PEA, N-palmitoylethanolamine; PLD, phospholipase type D
Supplementary key words N-acylethanolamines • stroke • ischemia • cannabinoid • endocannabinoid
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Caille, L. Alvarez-Jaimes, I. Polis, D. G. Stouffer, and L. H. Parsons Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration J. Neurosci., April 4, 2007; 27(14): 3695 - 3702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Muccioli, C. Xu, E. Odah, E. Cudaback, J. A. Cisneros, D. M. Lambert, M. L. Lopez Rodriguez, S. Bajjalieh, and N. Stella Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells J. Neurosci., March 14, 2007; 27(11): 2883 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lombardi, G. Miglio, F. Varsaldi, A. Minassi, and G. Appendino Oxyhomologation of the Amide Bond Potentiates Neuroprotective Effects of the Endolipid N-Palmitoylethanolamine J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Patel and C. J. Hillard Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 304 - 311. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
